MCM Vaccines B.V.
Quick facts
Marketed products
- Pediacel® · Immunology / Infectious Disease Prevention
Pediacel is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b.
Phase 3 pipeline
- Hib-MCC · Immunology / Infectious Disease
Hib-MCC is a conjugate vaccine that combines Haemophilus influenzae type b (Hib) polysaccharide with meningococcal C conjugate to stimulate immune protection against both pathogens. - MCC-CRM · Immunology / Infectious Disease
MCC-CRM is a meningococcal C conjugate vaccine that stimulates immune responses against Neisseria meningitidis serogroup C through conjugation of the polysaccharide capsule to a carrier protein. - MCC-TT · Immunology / Infectious Disease
MCC-TT is a therapeutic vaccine designed to stimulate immune responses against meningococcal and tetanus pathogens through conjugate technology. - PR5I · Immunology / Infectious Disease
PR5I is a therapeutic vaccine designed to stimulate immune responses against pneumococcal serotypes to prevent pneumococcal disease.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: